# Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites

> **NCT02881879** · PHASE1 · COMPLETED · sponsor: **Roxall Medicina España S.A** · enrollment: 43 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** Allergovac depot DPT/DF (50:50)

## Key facts

- **NCT ID:** NCT02881879
- **Lead sponsor:** Roxall Medicina España S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2017-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02881879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02881879, "Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02881879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*